ASweetLife Team, Author at ASweetLife

FDA Classifies Bydureon Complete Response as a Class 2 Resubmission

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced that the U.S. Food and Drug Administration has classified the Bydureon(TM) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010...

Novo Nordisk Anounces Victoza Cardiovascular Outcomes Trial

Novo Nordisk (NVO) announced today details of the company's cardiovascular outcomes trial for Victoza® (liraglutide [rDNA origin] injection), which is set to start in the autumn of 2010. The trial named LEADE aims to assess and confirm the cardiovascular safety of the company's new once-daily human GLP-1 analog Victoza...

Stem Cell Treatment for Type 1 Diabetes Receives FDA Orphan Drug Designation

Osiris Therapeutics, Inc. announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations...

White House Gives $15.8 Million for Utah Diabetes Program

The White House announced it would grant $15.8 million for a pilot program in Utah designed to help improve management of diabetes, according to a Desert News report.The grant is part of a $220 million stimulus-funded effort to expand use of electronic health records.The grant went to HealthInsight of Salt Lake City...

Nick Jonas and Bayer Diabetes Care Announce “Give Back. Simply Win.”

Bayer Diabetes Care announced it would be sponsoring a new contest, “Give Back. Simply Win.” The contest is designed to reward people with diabetes for their charitable efforts. Entering the contest is simple; it is open to people with diabetes in three age categories: 6 to 12, 13 to 17 and 18+ years...

Male Obesity Linked to Low Testosterone Levels

Obesity, a condition linked to heart disease and diabetes, now appears to be associated with another health problem, but one that affects men only - low testosterone levels. A new study conducted by University at Buffalo and published online ahead of print in the journal Diabetes Care, showed that 40 percent of obese participants...

Where Have You Flexed?

Novo Nordisk has announced an online insulin pen photo contest. The "Where Have You Flexed?" contest asks people who use the FlexPen to submit photos of themselves with their pen in unique locations. The grand prize winner will receive a trip for two to the Firestone Indy Lights championship in Miami on October 2 to see Charlie Kimball...

Roche’s Lucentis Effective for Diabetic Retinopathy

A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration. According to EurekAlert the study found that treating diabetic macular edema (DME) with Roche's ranibizumab (Lucentis) eye injections...

JDRF Funds Clinical Trial to Test Pig Islet Cells

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies (LCT), a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness....

Jonas Brothers Diabetes Benefit Concert

The Jonas Brothers are set to perform a concert at Danny DeVito’s house. The concert will benefit the Division of Endocrinology, Diabetes, & Metabolism at Children’s Hospital in Los Angeles. The event is in support of Dr. Francine Kaufman, Nick Jonas’ own diabetes doctor. Jonas was diagnosed with type 1 diabetes at the age of 13...